MicroRNA mediated regulation of oxidative stress and cytokines in Chlamydia trachomatis-infected recurrent

Ankita Ray1, Dibyabhaba Pradhan2, Fouzia Siraj3

  • 1Molecular Microbiology laboratory, ICMR-National Institute of Pathology, Sriramachari Bhawan, Safdarjung hospital campus, New Delhi, India.

Abstract

Insights

Circulating microRNAs (miRNAs) are implicated in Chlamydia trachomatis-associated recurrent spontaneous abortion (RSA). Dysregulated miRNAs correlate with oxidative stress and inflammation, suggesting their role in RSA pathogenesis.

Area of Science:

  • Reproductive immunology
  • Molecular biology
  • Infectious diseases

Background:

  • Increased oxidative stress (OS) and inflammation are key factors in Chlamydia trachomatis-associated recurrent spontaneous abortion (RSA).
  • MicroRNAs (miRNAs) regulate inflammatory and OS pathways, and their dysregulation is linked to pregnancy complications.

Purpose of the Study:

  • Investigate the expression and correlation of OS biomarkers, cytokines, and miRNAs in women with C. trachomatis-associated RSA.
  • Identify potential miRNA biomarkers for C. trachomatis-associated RSA.

Main Methods:

  • Collected urine and blood samples from RSA patients and healthy controls.
  • Detected C. trachomatis using PCR.
  • Analyzed miRNA expression via microarray and real-time PCR.
  • Quantified cytokine and antioxidant gene expression using real-time PCR.
  • Measured OS biomarkers (8-hydroxy guanosine and 8-isoprostane) via ELISA.

Main Results:

  • Fifty circulating miRNAs were differentially expressed in RSA patients compared to controls.
  • miR-8069 and miR-3663-3p showed significant upregulation/downregulation.
  • Elevated levels of cytokines (IL-8, TNF-α, IFN-γ), SOD2, 8-OHdG, and 8-IP were observed in RSA patients.
  • miR-8069 positively correlated with cytokines and OS biomarkers.

Conclusions:

  • Circulating miRNAs play a role in the pathogenesis of C. trachomatis-associated RSA.
  • These miRNAs may modulate cytokine signaling and OS in RSA.
  • miRNAs represent potential diagnostic or therapeutic targets for RSA.